This announcement is a separate document:
上海医药集团股份有限公司关于I040获得临床试验批准通知书的公告
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on I040 receiving a clinical trial approval notice
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.